Literature DB >> 6989166

Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn's disease, as indicated by micro-immunofluorescence antibody tests.

P A Mårdh, B Ursing, E Sandgren.   

Abstract

A significant difference has recently been reported in the occurrence of serum antibodies to the lymphogranuloma venereum (LGV) immunotypes of Chlamydia trachomatis in patients with Crohn's disease and controls. In the present study, sera from 107 patients with Crohn's disease, 33 males and 74 females, were tested for antibodies to C. trachomatis by an indirect immunofluorescence test, using two pools of antigens. These pools contained antigens to immunotypes TRIC D-K and LGV 1-3, respectively. None of the patients had IgM antibodies to the organism. IgG antibodies occurred significantly more often in the female than in male patients. No correlation could be demonstrated between activity and duration of Crohn's disease and the results of the antibody tests. For comparison, the sera of 50 puerperal women were studied. No difference in the occurence of IgG antibodies was found between patients and controls, neither when using the two pools of antigen, thus indicating that the antibodies detected had probably been induced by TRIC rather than LGV organisms. To conclude, the study did not indicate an association between Crohn's disease and infection with C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989166     DOI: 10.1111/j.1699-0463.1980.tb02604.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  10 in total

1.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 2.  Crohn's disease. New concepts of pathogenesis and current approaches to treatment.

Authors:  S P James; W Strober; T C Quinn; S H Danovitch
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

3.  Adoptive Transfer of Group 3-Like Innate Lymphoid Cells Restores Mouse Colon Resistance to Colonization of a Gamma Interferon-Susceptible Chlamydia muridarum Mutant.

Authors:  Ying He; Hong Xu; Chenchen Song; John J Koprivsek; Bernard Arulanandam; Huixiang Yang; Lijian Tao; Guangming Zhong
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

Review 4.  Chlamydia trachomatis: serological diagnosis.

Authors:  J D Treharne
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Isolation of Chlamydia trachomatis from the lower digestive tract.

Authors:  B Zöllner; H H Feucht; H Koch; L Iske; G Oehler; H J Stellbrink; R Laufs
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

6.  Deoxyribonucleic acid amplification and hybridisation in Crohn's disease using a chlamydial plasmid probe.

Authors:  B H McGarity; D A Robertson; I N Clarke; R Wright
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

7.  Lymphocytotoxic and microbial antibodies in Crohn's disease and matched controls.

Authors:  D Gump; E Caul; O Eade; H Greenberg; A Kapikian; B MacPherson; P Mitchell; K Parent; S Richmond; W Beeken
Journal:  Antonie Van Leeuwenhoek       Date:  1981-12       Impact factor: 2.271

8.  2017: beginning of a new era for Chlamydia research in China and the rest of the world.

Authors:  Huizhou Fan; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-10-06       Impact factor: 2.700

Review 9.  Chlamydia overcomes multiple gastrointestinal barriers to achieve long-lasting colonization.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2021-04-14       Impact factor: 17.079

10.  ELISA Serology for Antibodies Against Chlamydia trachomatis in Crohn's Disease.

Authors:  Herbert J Van Kruiningen; Zeinab Helal; Ariane Leroyer; Antonio Garmendia; Corrine Gower-Rousseau
Journal:  Gastroenterology Res       Date:  2018-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.